Group A (Ferrous Bisglycinate Chelate plus PABD) Group B (PABD) Statistical significance (analysis of variance for repeated measures) Number of patients 40 20   Δ Hb (g/dL) -0.65 ± 0.5 -1.115 ± 0.7 p<0.0001 Δ FER (ng/mL) -12.2 ± 8 -17.6 ± 7 p=0.155 (n.s.) Δ% TSAT -2.44% ± 5.5 -6.25% ± 8.2 p<0.0001 Δ% RET -0.47 ± 0.4 -0.17 ± 0.6 p=0.166 (n.s.) HRET 1.18 4.73   MRET 8.28 11.1   LRET 90.4 84.18

Table 2: Patient’s results (San Camillo-Forlanini Hospital). Δ Hb: Difference between Hb at T0 (before PABD) and T1 (ten days later); Δ FER: Difference between FER at T0 (before PABD) and T1 (ten days later); Δ% TSAT: Difference between % TSAT at T0 (before PABD) and T1 (ten days later); Δ% RET: Difference between % RET at T0 (before PABD) and T1 (ten days later); HRET = Reticulocytes with High RNA counter; MRET: Reticulocytes with Medium RNA Counter; LRET: Reticulocytes with Low RNA Counter.